Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > REGULATORY
REGULATORY
- CSIMC OKs NHI Price Listing of JT’s Anti-HIV Drug Stribild on Emergency Basis
April 11, 2013
- New Flu Act to Take Effect on April 13
April 11, 2013
- Japan Launches Strategic Fund for Drug R&D in Developing World
April 10, 2013
- MHLW Issues Order for Improvement to 5 Generic Companies due to GMP Violations by South Korean Supplier
April 9, 2013
- MHLW Unveils Generic Roadmap, Aims for 60%-Share by FY2017
April 8, 2013
- Expert Council on Cancer Research of MHLW, MEXT, METI to Hold 1st Meeting on April 15 to Discuss Future Cancer Research Strategy
April 8, 2013
- Eisai’s HTA-Savvy Tsuchiya Picked as CSIMC Expert Member
April 5, 2013
- FPMAJ Calls for PAL Amendment to Allow Applications Based on Information in Public Domain for Ultra-Orphan Drugs
April 5, 2013
- HIB Director-General Kikura Calls for Discussions on Pricing Rules for Combination Products Containing OTC Drugs
April 5, 2013
- Astem Pres. Yoshimura Says Wholesalers Should Break Away from Dependence on Long-Listed Drugs
April 4, 2013
- Prime Minister Abe Asks Ministries to Begin Discussions Toward Establishing Japanese Version of NIH
April 2, 2013
- Hodanren Calls for Inclusion of Pharmacies’ Technical Fees in Domestic Drug Prices When Comparing Drug Prices in Japan, US, and Europe
April 1, 2013
- MOF Budget Examiner Hirotsugu Shinkawa Hopes to See New Generic Target Set at Highest Share Achievable at Fastest Pace
March 29, 2013
- MHLW’s Generic Roadmap Compilation in Homestretch
March 29, 2013
- MHLW Committee Calls for New Name for Norvasc or Nolvadex to Prevent Further Prescribing Errors
March 29, 2013
- PFSB Notification Calls for Revisions of Precautions for Gabapentin, Other Drugs
March 28, 2013
- MHLW to Request Development of 2 Unapproved Indications Determined to Have Unmet Medical Needs
March 27, 2013
- PAFSC Committee Approves Reclassification of Tiquizium Bromide and Diclofenac as Class 2 OTC Drugs
March 26, 2013
- Administrative Evaluation: Health Ministry Urged to Review All-Specification Listing Requirement for Generics
March 25, 2013
- LDP Subcommittee Begins Discussions on Amending PAL; Bill Expected to Be Submitted During Current Diet Session
March 25, 2013
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…